Institutes outside Greece
Prenatal stress and the fetal gut: potential interventions to prevent adverse outcomes
Abstract
dc:descriptionChorioamnionitis and fetal hypoxia-ischemia (HI) are two antenatal pathological conditions which are associated with increased risk of postnatal intestinal morbidity. Inflammation is considered as an essential component in the induction of organ injury after chorioamnionitis and fetal HI. Therefore, the studies described in this dissertation aimed to provide insight in the inflammatory responses and subsequent developmental processes in the fetal gut induced by chorioamnionitis or fetal HI. In addition, we focused on exploring potential therapeutic interventions in utero to prevent intestinal inflammation and injury associated with these two pathological conditions. For these purposes, we used the well characterized translational ovine models as the development of the fetal ovine intestine is comparable to human. In Chapter 2, the relative contribution of selective IL-1α exposure to fetal mucosal surfaces (i.e. lung, gut and chorioamnion/skin) in the induction of intestinal inflammation and injury were investigated. Previous studies in an ovine model of chorioamnionitis have shown that inhibition of IL-1 signaling largely prevents chorioamnionitis-induced gut inflammation and damage. Nevertheless, the impact of IL-1α-driven immune activation of the gut or extraintestinal tissues on the outcome of the fetal intestine has not been investigated. For this purpose, IL-1α was selectively infused to different isolated fetal compartments (gut, lung and chorioamnion/skin) and intestinal histological changes were assessed. Our findings showed that intestinal inflammation was provoked by both direct IL-1α exposure to the intestinal mucosa and indirect IL-1α-mediated immune responses driven by the lung and chorioamnion/skin. In addition, mucosal damage and altered maturation of the fetal gut were exclusively provoked by direct IL-1α exposure. These results suggest that the local IL-1α-driven intestinal inflammatory response is fundamentally involved in the pathological features of the fetal gut in the context of chorioamnionitis. Since inflammatory changes in the fetal intestine can also be induced upon IL-1α exposure of the fetal lung and chorioamnion/skin, future therapeutic strategies should focus on targeting both intestinal and extraintestinal immune responses to reduce gut morbidity after chorioamnionitis. In Chapter 3, the potential therapeutic value of intestinal regulatory T (Treg) cell expansion with the cytokine IL-2 in the context of experimental chorioamnionitis was evaluated. Treg cells are crucial mediators of immune homeostasis in different organs including the intestine. Previous studies have shown that chorioamnionitis decreased the Treg/T effector (Teff) cell balance in the gut, which was accompanied by intestinal inflammation and mucosal injury. Therefore, in chapter 3 it was hypothesized that preferential expansion of Treg cells in the fetal gut by prophylactic IL-2 treatment would prevent the fetus from adverse intestinal outcomes in the course of chorioamnionitis. To test this hypothesis, fetal sheep were intra-amniotically exposed to lipopolysaccharide, with or without prophylactic intravenous IL-2 treatment. We found that systemic IL-2 administration resulted in an improved Treg/Teff cell ratio in the fetal gut. Importantly, when animals received prophylactic IL-2 treatment, chorioamnionitis-induced intestinal inflammation and mucosal damage were prevented. These findings indicate that boosting fetal Treg cells could be beneficial in case of chorioamnionitis-related intestinal complications. In Chapter 4, the pathological intestinal changes as a consequence of Candida albicans (C.albicans)-mediated chorioamnionitis were studied. Although chorioamnionitis is commonly caused by bacterial infection of the amniotic cavity, fungi including C.albicans are also linked with intrauterine infection. In chapter 4 we also evaluated whether the antifungal drug fluconazole protected the fetal gut after C.albicans-induced chorioamnionitis. To address these issues, intra-amniotic (IA) injections with C.albicans were given to pregnant sheep before preterm delivery. In addition, in utero fluconazole treatment was given 2 days after the IA C.albicans infection. We found that IA C.albicans infection caused intestinal colonization and mucosal invasion with concomitant epithelial damage and inflammation of the fetal gut. Although fluconazole treatment decreased intestinal C.albicans colonization and mucosal injury, anti-fungal treatment did not attenuate intestinal inflammation. These data imply that although in utero fluconazole treatment may be a therapeutic strategy in case of C.albicans-mediated chorioamnionitis, more comprehensive treatment strategies which can completely prevent C.albicans-induced intestinal inflammation and injury should be investigated. In Chapter 5, the pathological changes that occur in the fetal gut after global HI were examined. Similar to chorioamnionitis, global fetal HI is associated with detrimental postnatal intestinal outcomes, with inflammation being a key component involved in the underlying pathology. Since mesenchymal stem cells (MSCs) have been previously used to prevent HI-induced intestinal damage of the adult intestine, we administered MSCs as a potential approach to attenuate the adverse effects on the fetal intestine as a consequence of global HI. To address our aims, fetal sheep were subjected to umbilical cord occlusion (UCO), with or without intravenous MSC treatment. Global HI induced by UCO, resulted in intestinal inflammation, muscle thickening, distortion of enteric glial cells and altered neurotransmission. A single dose of intravenous MSC treatment at 1 hour after UCO did not ameliorate these HI-induced adverse intestinal consequences. Since the chosen MSC treatment regimen failed to ameliorate these detrimental intestinal effects, future research is needed to reveal a comprehensive cell-based therapy to protect the fetal gut after global HI. In conclusion, in this dissertation evidence is provided that chorioamnionitis and global fetal HI induce intestinal inflammation which was associated with epithelial injury and impaired development of the gut and enteric nervous system (ENS). Although in this dissertation the postnatal consequences of these prenatal events were not explored, the reported pathological changes in the fetal gut are linked with neonatal pathologies including necrotizing enterocolitis (NEC). In addition, this thesis tested novel strategies for protecting the fetal gut against the detrimental intestinal consequences associated with antenatal inflammation and global HI. The findings obtained during this PhD contribute to the development of more comprehensive therapeutic strategies to treat and/or prevent gut-related complications following chorioamnionitis and fetal HI.
Degree
thesis:*- Grantor dc:publisher
- Institutes outside Greece
- Year dc:date
- 2016
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Nikiforou, Maria
- Νικηφόρου, Μαρία
Subjects
dc:subject × 22- Φλεγμονή
- Ανοσοποιητικό σύστημα
- Εμβρυϊκή υποξία
- Έμβρυο
- Βλαστοκύτταρα
- Inflammation
- Immune system
- Fetal hypoxia
- Fetus
- Stem cells
- Βιολογία
- Φυσικές Επιστήμες
- Βιολογία, άλλοι τομείς
- Άλλες Ιατρικές Επιστήμες
- Ιατρική και Επιστήμες Υγείας
- Ιατρική έρευνα και Πειραματική ιατρική
- Biological Sciences
- Natural Sciences
- Biology, miscellaneous
- Other Medical Sciences
- Medical and Health Sciences
- Research and Experimental medicine
Rights
- Language dc:language
- eng
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/52486